Myriad Genetics Says It Will Fill Gap In Cancer Risk Prediction
This article was originally published in The Gray Sheet
Executive Summary
Myriad Genetics plans to release an advanced predict-tive genetic test for breast and ovarian cancer later this year, in line with study recommendations put forth in the Journal of the American Medical Association